| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |